Key result
Hand, Foot, and Mouth Disease is a viral illness primarily affecting children under five, for which prevention relies on WHO guidelines due to the lack of specific treatments or vaccines.
This review highlights the epidemiology, diagnosis, and prevention strategies for Hand, Foot, and Mouth Disease, emphasizing the lack of specific treatments and the importance of WHO guidelines.
Emphasizes supportive care and WHO prevention in HFMD outbreaks; leaves open targeted therapy development for trials.
HFMD is an obvious disease in children mostly below the age of five constituting a public health challenge to Asian-Pacific and developing countries majorly. This disease is often caused by enterovirus 71 (EV71) and Coxsackievirus A16. HFMD is a mild degree fever and general illness which manifests for about 10 days. Young age, male gender, poor hygiene, and high social contacts are some risk factors. HFMD can be diagnosed clinically by isolating the virus from stool and pharynx and identifying it on Light microscopic examination. Polymerase Chain Reaction Assay is a gold standard for confirming the virus from swabbed lesions. Late confirmation could lead to severe complications. There are no specific treatments and vaccines licensed for general use in the treatment of various serotypes of HFMD. The major strategy to prevent and control this disease is to strictly follow the WHO 8 guidelines to curb the spread of the disease.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2023) conducted a review in Hand, Foot, and Mouth Disease. Hand, Foot, and Mouth Disease is a viral illness primarily affecting children under five, for which prevention relies on WHO guidelines due to the lack of specific treatments or vaccines.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: